Exposure to organic solvents and multiple sclerosis

Neurology

Volumn 49, Issue 2 SUPPL., 1997, Pages 70-74

  Landtblom, Anne Marie ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC SOLVENT;

CASE CONTROL STUDY; CONFERENCE PAPER; DISEASE ASSOCIATION; ECOLOGY; ENVIRONMENTAL EXPOSURE; HUMAN; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; ECOLOGY; ENVIRONMENTAL EXPOSURE; HUMANS; MULTIPLE SCLEROSIS; PREVALENCE; SOLVENTS;

EID: 0030750207     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Slavin RE. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol 1995;1:9-18.
2. Landtblom AM, Flodin U, Söderfeldt B, Wolfson C, Axelson O. Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology 1996;7:429-433.
3. Flodin U, Söderfeldt B, Noorlind Brage H, Fredriksson M, Axelson O. Multiple sclerosis, solvents and pets: a case-referent study. Arch Neurol 1988;45:620-623.
4. Amaducci L, Arfaioli C, Inzitari D, Marci M. Multiple sclerosis among shoe and leather workers: an epidemiological survey in Florence. Acta Neurol Scand 1982;65:94-103.
5. Juntunen J, Kinnunen E, Antti-Poika M, Koskenvuo M. Multiple sclerosis and occupational exposure to chemicals: a co-twin control study of a nationwide series of twins. Br J Indust Med 1989;46:417-419:1-123.
6. Koch-Henriksen N. An epidemiological study of multiple sclerosis. Acta Neurol Scand 1989;80(suppl 124):1-123.
7. Souberbielle BE, Martin-Mondiere C, O'Brien ME, Carydakis C, Cesaro P, Degos JD. A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta Neurol Scand 1990;82:303-310.
8. Hopkins RS, Indian RW, Pinnow E, Garrison RP. Multiple sclerosis in Galion, Ohio: prevalence and results of a case-control study. Neuroepidemiology 1991;10:192-199.
9. Grønning M, Albrektsen G, Kvåle G, Moen B, Aarli JA, Nyland H. Organic solvents and multiple sclerosis: a case-control study. Acta Neurol Scand 1993;88:247-250.
10. Landtblom AM, Flodin U, Karlsson M, Pålhagen S, Axelson O. Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scand J Work Environ Health 1993;19:399-404.
11. Nelson NA, Robins TG, White RF, Garrison RP. A case-control study of chronic neuropsychiatric disease and organic solvent exposure in automobile plant workers. Occup Environ Med 1994;51:302-307.
12. Casetta I, Granieri E, Malagù S, et al. Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 1994;13:120-128.
13. Giuliani G, Brizoli E, Angeleri VA, Caraffa G, Foschih N, Speranzini C. The organic glue solvents in the pathogenesis of multiple sclerosis: an epidemiological study. International Multiple Sclerosis Conference, Rome, September 14-17, 1988. In: Battaglia MA, Crimi G, eds. An update on multiple sclerosis. Bologna: Monduzzi, 1989:243-247.
14. Angeleri F, Bollettini G, Brizoli E, Giuliani G, Scarpino O. A prevalence study of multiple sclerosis in the regione Marchi, Italy. International Multiple Sclerosis Conference, Rome, September 14-17, 1988. In: Battaglia MA, Crimi G, eds. An update on multiple sclerosis. Bologna: Monduzzi, 1989:211.
15. Milham S. Occupational mortality in Washington State 1950-1979. Cincinnati: U.S. Department of Health and Human Services, Centers for Disease Control, 1983: 1663-1664 (NIOSH Publication No. 83-116).
16. Lauer K. Risk of multiple sclerosis in relation to industrial activities: an ecological study in four European countries. Neuroepidemiology 1989;8:38-42.
17. Lauer K. Mortality of multiple sclerosis in relation to geographic factors in France. Neuroepidemiology 1990;9:113-117.
18. Axelson O. Principles of occupational epidemiology. In: Waldron HA, ed. Occupational health practice. London: Butterworths, 1989:279-298.
19. Moen BE, Kyvik KR, Engelsen BA, Riise T. Cerebrospinal fluid proteins and free amino acids in patients with solvent induced chronic toxic encephalopathy and healthy controls. Br J Indust Med 1990;47:277-280.
20. Wikkelsö C, Ekberg K, Lillienberg L, et al. Cerebrospinal fluid proteins and cells in men subjected to long-term exposure to organic solvents. Acta Neurol Scand Suppl 1984;70(suppl 100):113-119.
21. Barregård L, Wikkelsö C, Rosengren LE, Aurell A, Thiringer G, Nilson L. Cerebrospinal fluid proteins in men with chronic encephalopathy after exposure to organic solvents. Scand J Work Environ Health 1990;16:423-427.
22. Axelson O, Hogstedt C. The health effects of solvents. In: Zenz C, Dickerson OB, Horvath EP Jr, eds. Occupational medicine. St Louis: Mosby, 1994:764-778.
23. Vergani D, Mieli Vergani G, Alberti A, et al. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 1980;303:66-71.
24. Vianna NJ, Polan A. Lymphomas and occupational benzene exposure. Lancet 1979;30:1394-1395.
25. Moszczynski P. Organic solvents and T-lymphocytes. Lancet 1981;21:438.
26. Juntunen J, Taskinen E, Luisto M, Iivanainen M, Nurminen M. Cerebrospinal fluid cells and proteins in patients occupationally exposed to organic solvents. J Neurol Sci 1982;54:413-425.